InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,527.37
(
1.32%
)
US TECH 100
18,945.60
(
2.36%
)
Dow Jones
40,461.33
(
1.13%
)
Brent Oil
80.73
(
1.39%
)
Bitcoin
59,482.99
(
1.31%
)
Post# of 403281
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

williamssc

Send PM Follow Ignore
Followers 43
Posts 5514
Boards Moderated 0
Alias Born 11/15/2013

williamssc

Re: To infinity and beyond! post# 343612

Wednesday, 02/03/2021 5:20:49 PM

Wednesday, February 03, 2021 5:20:49 PM

Post# of 403281
Brilacidin performed excellent in our IPIX human trial for the treatment of acute bacterial skin and skin structure infections. One IV treatment was all that was needed for B to pierce the bacterial wall and kill the disease. MOA is the same... piercing the viral wall. Yes trial could fail, be mediocre or be a huge success. I like to think our absssi trial is a indicator of success. We shall soon see.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED POET Technologies Reports Second Quarter 2024 Financial Results • Aug 15, 2024 8:04 AM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM

Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM

ATWEC Reaches Profitability, Announces Massive Earnings Growth, and a Strong Forecast for the Rest of 2024 • ATWT • Aug 15, 2024 7:16 AM

Alliance Creative Group (ACGX) Releases Q2 2024 Financial and Disclosure Report with an increase of over $130,000 in Net Income from Q2 2023 to Q2 2024 • ACGX • Aug 14, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!